Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfluramine for Adult Dravet patients
NCT05560282Phase 3Terminated
- Sponsor
- University Health Network
- Start
- Jan 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenfluramine in Dravet syndrome, sponsored by University Health Network. Started Jan 2023; status: terminated.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT05560282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05560282.